Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $977.83, with a 24-hour trading volume of $1.77B. The asset's market cap is $873.19B, after moving -2.26% in the last day.
Tokenized Eli Lilly And Co is trading at $982.77, with a tokenized market cap of $5.37M and a 24-hour trading volume of $2.26M. The tokenized asset has moved -2.08% in the past 24 hours.